---
document_datetime: 2023-09-21 18:20:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/ovitrelle-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: ovitrelle-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.3733468
conversion_datetime: 2025-12-24 17:40:35.393397
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

## For procedures finalised after 1 August 2004 please refer to module 8B.

## MAJOR CHANGES

| No      | Scope                                                    | Opinion issued on   | Commission Decision Issued/ amended on   | Summary                                                                         |
|---------|----------------------------------------------------------|---------------------|------------------------------------------|---------------------------------------------------------------------------------|
| X/007   | Line extension : addition of a new pharmaceutical form   | 24/07/2003          | 24/10/2003                               | Additional pharmaceutical form: solution for injection in a pre- filled syringe |
| II/0012 | Change to an analytical method and related specification | 25/09/2003          | 02/10/2003                               | Alternative method to quantify the carbohydrate content of luteinising hormone  |

## MINOR CHANGES

(Type I variations, Notifications)

| No     | Scope                                                                                                  | Notification issued on 1   |
|--------|--------------------------------------------------------------------------------------------------------|----------------------------|
| I/0001 | Change in the name of the medicinal product (either invented name of common name)                      | 20/07/2001                 |
| I/0002 | Change in the name and/or address of the marketing authorisation holder                                | 20/07/2001                 |
| I/0003 | Change in specification of starting material/intermediate used in manufacturer of the active substance | 22/03/2002                 |
| I/0004 | Change in or addition of manufacturing site(s) for part or all of the manufacturing process            | 13/09/2002                 |
| I/0005 | Change in the name of a manufacturer of the medicinal product                                          | 21/08/2002                 |
| I/0006 | Change in supplier of an intermediate compound used in manufacture of the active substance             | 21/08/2002                 |
| I/0008 | Change in in-process controls applied during the manufacture of the product                            | 16/01/2003                 |
| N/0009 | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)       | 10/02/2003                 |
| I/0010 | Change in name of manufacturer or actual site of manufacture                                           | 08/09/2003                 |
| I/0011 | Change in container shape                                                                              | 08/10/2003                 |
| I/0013 | Change in ATC code                                                                                     | 27/11/2003                 |
| I/0014 | Change in the shelf-life of the finished product                                                       | 10/03/2004                 |
| N/0015 | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)       | 27/07/2004                 |

## Ovitrelle

ï£©